PRISM evaluates 4D-150, a potential backbone therapy designed to provide multi-year sustained delivery of anti-VEGF ...

D Molecular Therapeutics reported 52-week Phase 2b data for 4D-150 in wet AMD, showing sustained visual acuity improvements.

Confused about what pundits are talking about when a college basketball team's Quad 1 wins? Here's a look at understanding the difference in victories for teams bidding for a trip to the NCAA ...

And, even though it may look dangerous, it is not. "No, laughing does not cause any harm to the baby. Babies in the womb feed ...